Speaker(s): 

Travis Taylor, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives

At the conclusion of this session, the participant should be able to: 

1. Examine and interpret the recent data from the CHOICE 2 trial

2. Compare more recent yet unpublished data on post thrombectomy trials (eg TECNO)

3. Utilize the above information to review/revise future recommendations from the vascular Neurology department

After viewing this session, the participants should be able to answer the following questions:

What are your thoughts/ideas on current recommendations from our department on post thrombectomy tPA/tnk

-Any thoughts or ideas on why outcomes may have differed in these two studies

-Any thoughts on how this may change recommendations moving forward as a department?

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD, David Ermak, DO, Lisa Wasko, BSN, RN, SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None